Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion
Launched by ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE · Mar 11, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the impact of preparing patients for a fecal diversion stoma, a surgical procedure that creates an opening in the abdomen for waste removal, on their quality of life and the number of complications that may arise. The researchers want to see how identifying and educating patients about their stoma before surgery can help improve their experience and reduce issues such as pain or difficulty adjusting to the stoma after surgery. They will compare two groups of patients: one group will receive preoperative education and support, while the other group will not.
To be eligible for this trial, participants must be adults aged 18 or older who are scheduled for this type of surgery, whether planned ahead of time or in an emergency. They also need to be part of the French social security system. During the study, participants can expect to receive follow-up care for 12 months after their surgery to assess their recovery and quality of life. It's important to note that the trial is not yet recruiting participants, and the total length of the study will be two years.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men or women aged 18 and over
- • for whom a fecal diversion stoma is planned on a scheduled or emergency basis
- • affiliated with the French social security system
- Exclusion Criteria:
- • Patient in a period of exclusion from another research protocol at the time of signing the no-objection form,
- • Subjects covered by articles L1121-5 to 1121-8 of the French Public Health Code (minors, adults under guardianship or trusteeship, patients deprived of their liberty, pregnant or breast-feeding women),
- • No digestive stoma or fecal diversion planned
- • Person who does not understand French
About Assistance Publique Hopitaux De Marseille
Assistance Publique - Hôpitaux de Marseille (AP-HM) is a leading public healthcare institution in France, dedicated to providing high-quality medical care and advancing research in various clinical fields. As a prominent sponsor of clinical trials, AP-HM is committed to fostering innovation and improving patient outcomes through rigorous scientific investigation. With a multidisciplinary approach, the institution collaborates with a network of healthcare professionals, researchers, and academic partners to facilitate cutting-edge studies that address critical health challenges. AP-HM's dedication to ethical standards and patient safety underscores its role as a trusted leader in clinical research and healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported